Concert Looks To Phase III In Alopecia Areata, Ahead Of Pfizer’s JAK Inhibitor

 
• By Joseph Haas
Desperate Young Man Touching His Bald Patches - Image
Concert hopes to bring the first drug therapy for alopecia areata to market

More from Clinical Trials

More from R&D